Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Targeting CD200 could be a new treatment for rheumatoid arthritis.